Evolving treatment paradigms in recurrent and metastatic head and neck squamous cell carcinoma: the emergence of immunotherapy

被引：1
|
作者：
Faraji, Farhoud [1 ]
Cohen, Ezra E. W. [2 ]
Guo, Theresa W. [1 ]
机构：
[1] UC San Diego Hlth, Gleiberman Head & Neck Canc Ctr, Moores Canc Ctr, Dept Otolaryngol Head & Neck Surg, La Jolla, CA USA
[2] UC San Diego Hlth, Dept Internal Med, Gleiberman Head & Neck Canc Ctr, Moores Canc Ctr,Div Hematol Oncol, La Jolla, CA USA
来源：
TRANSLATIONAL CANCER RESEARCH | 2023年 / 12卷 / 05期
关键词：
Immunotherapy; salvage surgery; head and neck squamous cell carcinoma (HNSCC); HUMAN-PAPILLOMAVIRUS; INVESTIGATORS CHOICE; COMORBIDITY INDEX; MUTATIONAL BURDEN; SURGICAL SALVAGE; PD-1; BLOCKADE; CHECKMATE; 141; OPEN-LABEL; SURVIVAL; CANCER;
D O I：
10.21037/tcr-23-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1353 / 1358
页数：6
相关论文
共 50 条
  • [21] Pembrolizumab for recurrent/metastatic head and neck squamous cell carcinoma in an Asian population
    Chen, Wen-Chun
    Chu, Pen-Yuan
    Lee, Yu-Ting
    Lu, Wen-Bin
    Liu, Chun-Yu
    Chang, Peter Mu-Hsin
    Yang, Muh-Hwa
    MEDICINE, 2017, 96 (52)
  • [22] Alpelisib and Immunotherapy: A Promising Combination for Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck
    Suleiman, Riham
    McGarrah, Patrick
    Baral, Binav
    Owen, Dawn
    Aguilera, Jesus Vera
    Halfdanarson, Thor R.
    Price, Katharine A.
    Bayne, Harry E. Fuentes
    CANCER REPORTS, 2024, 7 (10)
  • [23] Safety and Treatment Outcomes of Nivolumab for the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Retrospective Multicenter Cohort Study
    Vasiliadou, Ifigenia
    Breik, Omar
    Baker, Holly
    Leslie, Isla
    Sim, Van Ren
    Hegarty, Gemma
    Michaelidou, Andriana
    Nathan, Kannon
    Hartley, Andrew
    Good, James
    Sanghera, Paul
    Fong, Charles
    Urbano, Teresa Guerrero
    Lei, Mary
    Petkar, Imran
    Ferreira, Miguel Reis
    Nutting, Chris
    Wong, Kee Howe
    Newbold, Kate
    Harrington, Kevin
    Bhide, Shree
    Kong, Anthony
    CANCERS, 2021, 13 (06) : 1 - 12
  • [24] Correlates of Cetuximab Efficacy in Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma Previously Treated With Immunotherapy
    Park, Jong Chul
    Ahn, Jong Seok
    Merkin, Ross
    Patel, Manisha
    Wirth, Lori
    Roberts, Thomas J.
    JCO PRECISION ONCOLOGY, 2025, 9
  • [25] New Challenges in Evaluating Outcomes after Immunotherapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
    Alberti, Andrea
    Lorini, Luigi
    Ravanelli, Marco
    Perri, Francesco
    Vinches, Marie
    Rondi, Paolo
    Romani, Chiara
    Bossi, Paolo
    VACCINES, 2022, 10 (06)
  • [26] Immunotherapy Advances in Locally Advanced and Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Its Relationship With Human Papillomavirus
    Wang, Huanhuan
    Zhao, Qin
    Zhang, Yuyu
    Zhang, Qihe
    Zheng, Zhuangzhuang
    Liu, Shiyu
    Liu, Zijing
    Meng, Lingbin
    Xin, Ying
    Jiang, Xin
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [27] Therapeutic perspectives for recurrent or metastatic head and neck squamous cell carcinoma
    Gauduchon, Thibault
    Neidhardt, Eve Marie
    Fayette, Jerome
    CURRENT OPINION IN ONCOLOGY, 2025, 37 (03) : 175 - 183
  • [28] Advances in the management of recurrent or metastatic squamous cell carcinoma of the head and neck
    Shin, Dong M.
    Khuri, Fadlo R.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2013, 35 (03): : 443 - 453
  • [29] Novel Systemic Treatment Modalities Including Immunotherapy and Molecular Targeted Therapy for Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma
    Ghosh, Soma
    Shah, Pooja A.
    Johnson, Faye M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (14)
  • [30] Current status of systemic therapy for recurrent and/or metastatic squamous cell carcinoma of the head and neck
    Jacob, L. A.
    Chaudhuri, T.
    Lakshmaiah, K. C.
    Babu, K. G.
    Dasappa, L.
    Babu, M. C. S.
    Rudresha, A. H.
    Lokesh, K. N.
    Rajeev, L. K.
    INDIAN JOURNAL OF CANCER, 2016, 53 (04) : 1 - 7
12345